Risk Factors

The success of Orgenesis in achieving the results depicted in this website are subject to a number of risks, which include, among other things: our technology may not be validated as we progress further; our methods may not be accepted by the scientific community; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties may develop with our process; results in the laboratory may not translate to equally good results in real surgical settings; potential successful challenges to our patents; that our patents are not sufficient to protect essential aspects of our technology; that competitors may invent better technology; that we may not have sufficient financing to develop our products; our products may not work as well as hoped or worse, they may harm recipients; that we may not be able raise funding for development or working capital when we require it; our products may never develop into useful products and even if they do, they may not be approved for sale to the public; that we have substantial hurdles to face in obtaining regulatory approval in each country in which our technology may be sold; and other factors beyond our control. Additional information about these and other assumptions, risks and uncertainties are set out in the “Risk Factors” section in the company’s 8-K filed February 8, 2012, and in its most recent 10-K filed on EDGAR with the Securities and Exchange Commission.

Back to Top